Marsha Zeigler

2.3k total citations
19 papers, 618 citations indexed

About

Marsha Zeigler is a scholar working on Physiology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Marsha Zeigler has authored 19 papers receiving a total of 618 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Physiology, 6 papers in Molecular Biology and 5 papers in Organic Chemistry. Recurrent topics in Marsha Zeigler's work include Lysosomal Storage Disorders Research (14 papers), Calcium signaling and nucleotide metabolism (5 papers) and Carbohydrate Chemistry and Synthesis (5 papers). Marsha Zeigler is often cited by papers focused on Lysosomal Storage Disorders Research (14 papers), Calcium signaling and nucleotide metabolism (5 papers) and Carbohydrate Chemistry and Synthesis (5 papers). Marsha Zeigler collaborates with scholars based in Israel, United States and France. Marsha Zeigler's co-authors include Gideon Bach, Hanna Mandel, Annick Raas‐Rothschild, Ruth Bargal, Ronen Spiegel, Valérie Cormier‐Daire, William M. Canfield, Arnold Munnich, Emmanuelle Génin and Ming Bao and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Lipid Research and Journal of the American Academy of Dermatology.

In The Last Decade

Marsha Zeigler

19 papers receiving 605 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marsha Zeigler Israel 14 433 196 179 177 100 19 618
Gloria Stephney United States 7 393 0.9× 140 0.7× 167 0.9× 159 0.9× 115 1.1× 7 624
Kyle Peake Canada 11 355 0.8× 106 0.5× 173 1.0× 95 0.5× 104 1.0× 15 582
Mukarram El-Banna United States 7 412 1.0× 222 1.1× 217 1.2× 104 0.6× 87 0.9× 8 571
Jennifer A. Wiseman United States 8 383 0.9× 212 1.1× 216 1.2× 100 0.6× 86 0.9× 9 553
Joshua W Sokol United States 5 436 1.0× 149 0.8× 251 1.4× 93 0.5× 50 0.5× 6 646
Takanobu Otomo Japan 17 430 1.0× 236 1.2× 238 1.3× 182 1.0× 291 2.9× 34 746
Daniëlle te Vruchte United Kingdom 12 505 1.2× 162 0.8× 448 2.5× 127 0.7× 194 1.9× 18 939
Nicole Y. Farhat United States 15 409 0.9× 58 0.3× 157 0.9× 89 0.5× 94 0.9× 32 579
Maria Prociuk United States 8 286 0.7× 72 0.4× 112 0.6× 61 0.3× 79 0.8× 10 396

Countries citing papers authored by Marsha Zeigler

Since Specialization
Citations

This map shows the geographic impact of Marsha Zeigler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marsha Zeigler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marsha Zeigler more than expected).

Fields of papers citing papers by Marsha Zeigler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marsha Zeigler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marsha Zeigler. The network helps show where Marsha Zeigler may publish in the future.

Co-authorship network of co-authors of Marsha Zeigler

This figure shows the co-authorship network connecting the top 25 collaborators of Marsha Zeigler. A scholar is included among the top collaborators of Marsha Zeigler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marsha Zeigler. Marsha Zeigler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Zeigler, Marsha, Vardiella Meiner, J. P. Newman, et al.. (2014). A novel SCARB2 mutation in progressive myoclonus epilepsy indicated by reduced β-glucocerebrosidase activity. Journal of the Neurological Sciences. 339(1-2). 210–213. 18 indexed citations
2.
Zlotogora, Joël, et al.. (2011). Genetic screening for Krabbe disease: Learning from the past and looking to the future. American Journal of Medical Genetics Part A. 155(3). 574–576. 7 indexed citations
3.
Mandel, Hanna, Deeksha Bali, Priya S. Kishnani, et al.. (2011). Treatment Outcome of Pompe Disease Infants with Negative Cross-Reactive Immunologic Material From Israel and Gaza. Clinical Therapeutics. 33(6). S17–S17. 1 indexed citations
4.
Spiegel, Ronen, Annick Raas‐Rothschild, Orit Reish, et al.. (2009). The clinical spectrum of fetal Niemann–Pick type C. American Journal of Medical Genetics Part A. 149A(3). 446–450. 68 indexed citations
5.
Kogot‐Levin, Aviram, Marsha Zeigler, Asher Ornoy, & Gideon Bach. (2009). Mucolipidosis Type IV: The Effect of Increased Lysosomal pH on the Abnormal Lysosomal Storage. Pediatric Research. 65(6). 686–690. 38 indexed citations
6.
Molho‐Pessach, Vered, Ruth Bargal, Victoria Doviner, et al.. (2007). Angiokeratoma corporis diffusum in human β-mannosidosis: Report of a new case and a novel mutation. Journal of the American Academy of Dermatology. 57(3). 407–412. 15 indexed citations
7.
Zelnik, Nathanel, et al.. (2007). A Novel Mutation of the CLN8 Gene: Is There a Mediterranean Phenotype?. Pediatric Neurology. 36(6). 411–413. 19 indexed citations
8.
Bach, Gideon, Marsha Zeigler, & Joël Zlotogora. (2006). Prevention of lysosomal storage disorders in Israel. Molecular Genetics and Metabolism. 90(4). 353–357. 17 indexed citations
9.
Stein, Jerry, Ben Zion Garty, Yael Dror, et al.. (2006). Successful treatment of Wolman disease by unrelated umbilical cord blood transplantation. European Journal of Pediatrics. 166(7). 663–666. 49 indexed citations
10.
Bargal, Ruth, Marsha Zeigler, Bassam Abu‐Libdeh, et al.. (2006). When Mucolipidosis III meets Mucolipidosis II: GNPTA gene mutations in 24 patients. Molecular Genetics and Metabolism. 88(4). 359–363. 50 indexed citations
11.
Elstein, Deborah, C. Ronald Scott, Marsha Zeigler, Aya Abrahamov, & Ari Zimran. (2005). Phenotypic Heterogeneity in Patients with Gaucher Disease and the N370S/V394L Genotype. Genetic Testing. 9(1). 26–29. 7 indexed citations
12.
Zeigler, Marsha, et al.. (2005). The metabolism of glycosaminoglycans is impaired in prion diseases. Neurobiology of Disease. 20(3). 738–743. 20 indexed citations
13.
Korman, Stanley H., et al.. (2004). Prenatal diagnosis for arginase deficiency by second‐trimester fetal erythrocyte arginase assay and first‐trimester ARG1 mutation analysis. Prenatal Diagnosis. 24(11). 857–860. 9 indexed citations
14.
Spiegel, Ronen, et al.. (2004). A mutation in the saposin A coding region of the prosaposin gene in an infant presenting as Krabbe disease: first report of saposin A deficiency in humans. Molecular Genetics and Metabolism. 84(2). 160–166. 87 indexed citations
15.
Brautbar, Ariel, Deborah Elstein, Aya Abrahamov, et al.. (2003). The 1604A (R496H) mutation in Gaucher disease: genotype/phenotype correlation. Blood Cells Molecules and Diseases. 31(2). 187–189. 13 indexed citations
16.
Meiner, Vardiella, Shoshi Shpitzen, Hanna Mandel, et al.. (2001). Clinical-biochemical correlation in molecularly characterized patients with Niemann-Pick type C. Genetics in Medicine. 3(5). 343–348. 28 indexed citations
17.
Zschenker, Oliver, et al.. (2001). Characterization of lysosomal acid lipase mutations in the signal peptide and mature polypeptide region causing Wolman disease. Journal of Lipid Research. 42(7). 1033–1040. 27 indexed citations
18.
Raas‐Rothschild, Annick, Valérie Cormier‐Daire, Ming Bao, et al.. (2000). Molecular basis of variant pseudo-Hurler polydystrophy (mucolipidosis IIIC). Journal of Clinical Investigation. 105(5). 673–681. 136 indexed citations
19.
Gluck, Iris, Marsha Zeigler, Ruth Bargal, Elena Schiff, & Gideon Bach. (1998). Niemann Pick disease type A in Israeli Arabs: 677delT, a common novel single mutation. Human Mutation. 12(2). 136–136. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gloria Stephney Breakdown of academic impact, for papers by Kyle Peake Breakdown of academic impact, for papers by Mukarram El-Banna Breakdown of academic impact, for papers by Jennifer A. Wiseman Breakdown of academic impact, for papers by Joshua W Sokol Breakdown of academic impact, for papers by Takanobu Otomo Breakdown of academic impact, for papers by Daniëlle te Vruchte Breakdown of academic impact, for papers by Nicole Y. Farhat Breakdown of academic impact, for papers by Maria Prociuk
Rankless by CCL
2026